Angelo Ravelli
Handbook of Juvenile Idiopathic Arthritis
Angelo Ravelli
Handbook of Juvenile Idiopathic Arthritis
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This handbook is an in-depth and comprehensive guide for the treatment and management of patients with juvenile idiopathic arthritis. The handbook provides an informative review of the disease looking at the epidemiology, etiology and pathogenesis, issues of diagnosis and classification, consequences and complications, general treatment aspects, as well as both non pharmacologic and pharmacologic therapy whilst considering the future outlook for patients with juvenile idiopathic arthritis. Juvenile idiopathic arthritis is the most common type of arthritis found in children and adolescents,…mehr
Andere Kunden interessierten sich auch für
- Ronald M. LaxerPediatric Rheumatology in Clinical Practice88,99 €
- Systemic Corticosteroids for Inflammatory Disorders in Pediatrics74,99 €
- Handbook of Psoriasis and Psoriatic Arthritis52,99 €
- Cong-Qiu ChuTargeting the IL-17 Pathway in Inflammatory Disorders37,99 €
- Frederic ShapiroPediatric Orthopedic Deformities, Volume 1148,99 €
- Agammaglobulinemia74,99 €
- Treatment of the Obese Patient74,99 €
-
-
-
This handbook is an in-depth and comprehensive guide for the treatment and management of patients with juvenile idiopathic arthritis. The handbook provides an informative review of the disease looking at the epidemiology, etiology and pathogenesis, issues of diagnosis and classification, consequences and complications, general treatment aspects, as well as both non pharmacologic and pharmacologic therapy whilst considering the future outlook for patients with juvenile idiopathic arthritis. Juvenile idiopathic arthritis is the most common type of arthritis found in children and adolescents, affecting about 1 in 1,000 children. It is a chronic disease which causes inflammation, pain and swelling of the affected joints and can affect joints in any part of the body. This Handbook provides an unbiased, informative discussion of the current and emerging treatments in this field.
Produktdetails
- Produktdetails
- Verlag: Adis / Springer International Publishing / Springer, Berlin
- Artikelnr. des Verlages: 86363869, 978-3-319-08101-4
- 1st ed. 2016
- Seitenzahl: 140
- Erscheinungstermin: 30. Oktober 2015
- Englisch
- Abmessung: 203mm x 127mm x 8mm
- Gewicht: 163g
- ISBN-13: 9783319081014
- ISBN-10: 3319081012
- Artikelnr.: 41650075
- Verlag: Adis / Springer International Publishing / Springer, Berlin
- Artikelnr. des Verlages: 86363869, 978-3-319-08101-4
- 1st ed. 2016
- Seitenzahl: 140
- Erscheinungstermin: 30. Oktober 2015
- Englisch
- Abmessung: 203mm x 127mm x 8mm
- Gewicht: 163g
- ISBN-13: 9783319081014
- ISBN-10: 3319081012
- Artikelnr.: 41650075
Angelo Ravelli is Associate Professor of Pediatrics at the School of Medicine of the University of Genoa, Italy, a position held since 2006. He is Chief of the Centre of Clinimetrics of the Istituto Giannina Gaslini of Genoa, Italy, a position he has held since 2012. Previously, he was Chief of the Interventional Rheumatology Unit at the same institution. After completion of a degree in medicine, Dr Ravelli specialized in paediatrics and allergology. His field of clinical and research activity focuses on paediatric rheumatology. Dr Ravelli has been invited to speak in more than 200 national and international meetings and has published more than 220 full-length articles in international scientific journals, with a total impact factor of more than 1,200 and an h-index of 43. He has received numerous grants and awards, including the Gerolamo Prize for Excellence in Research in 2004. He is Associate Editor of Pediatric Rheumatology Online Journal, Assistant Editor of Clinical and Experimental Rheumatology and serves on the Editorial Board of The Journal of Rheumatology and Arthritis Care & Research. He is a member of the Executive Committee of the European Rheumatology Research Foundation and was Chairman of the Lupus Working Group of the Pediatric Rheumatology European Society (PReS) from 2004 to 2010.
Introduction Disease overviewEpidemiologyEtiology and pathogenesisEnvironmental factorsGenetic susceptibilityRole of humoral and cell-mediated immunityPathogenesis of systemic arthritisPathophysiology of macrophage activation syndrome
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspectsGoals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remissionTransition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspectsGoals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remissionTransition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Introduction Disease overview Epidemiology Etiology and pathogenesis Environmental factors Genetic susceptibility Role of humoral and cell-mediated immunity Pathogenesis of systemic arthritis Pathophysiology of macrophage activation syndrome
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspects Goals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remission Transition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspects Goals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remission Transition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Introduction Disease overviewEpidemiologyEtiology and pathogenesisEnvironmental factorsGenetic susceptibilityRole of humoral and cell-mediated immunityPathogenesis of systemic arthritisPathophysiology of macrophage activation syndrome
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspectsGoals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remissionTransition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspectsGoals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remissionTransition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Introduction Disease overview Epidemiology Etiology and pathogenesis Environmental factors Genetic susceptibility Role of humoral and cell-mediated immunity Pathogenesis of systemic arthritis Pathophysiology of macrophage activation syndrome
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspects Goals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remission Transition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook
Disease classification Classification criteria Challenges in classification
Clinical manifestations Systemic arthritis Rheumatoid factor-negative polyarthritis Rheumatoid factor-positive polyarthritis Oligoarthritis Enthesitis-related arthritis Psoriatic arthritis Undifferentiated arthritis
Diagnosis Clinical assessment Imaging Biomarkers Differential diagnosis
Consequences and complications Disease course of different subtypes Skeletal and growth abnormalities Ophthalmologic complications Macrophage activation syndrome
General treatment aspects Goals of treatment Measuring treatment response Treatment recommendations A multidisciplinary approach to treatment Special considerations in the pediatric patient
Management of patients with juvenile idiopathic arthritis Psychosocial factors Physical therapy Other non-pharmacologic interventions Non-steroidal anti-inflammatory drugs Intra-articular corticosteroids Systemic corticosteroids Conventional disease-modifying anti-rheumatic drugs Biologic disease-modifying anti-rheumatic drugs Safety of biologics Other pharmacologic interventions Management of iridocyclitis Management of macrophage activation syndrome
Specific issues Health-related quality of life Vaccination Treatment discontinuation after disease remission Transition to adult care
Outcome, prognosis and future outlook Long-term outcome and its prediction Mortality Future outlook